EFdA-TP tetraammonium is an influential nucleoside reverse transcriptase (RT) inhibitor that effectively prevents RT-mediated DNA synthesis by acting as an immediate or delayed chain terminator (ICT or DCT). Additionally, EFdA-TP tetraammonium exhibits multiple mechanisms of inhibiting HIV-1 RT[1].
Molecular Weight:
601.31
Formula:
C12H27N9O12P3
Target:
HIV Protease|||Reverse Transcriptase|||Others|||DNA/RNA Synthesis
T35649
* VAT and and shipping costs not included. Errors and price changes excepted
